The bidirectional association of epilepsy with Alzheimer's disease and other neurodegenerative dementias: A longitudinal observational study on the UK Biobank
Restricted accessResearch articleFirst published online 2026
The bidirectional association of epilepsy with Alzheimer's disease and other neurodegenerative dementias: A longitudinal observational study on the UK Biobank
Converging evidence supports a bidirectional link between epilepsy and Alzheimer's disease (AD). Limited data are available regarding the association of epilepsy with frontotemporal dementia (FTD) and dementia with Lewy bodies (DLB).
Objective
To estimate the bidirectional association between epilepsy and AD, FTD, and DLB in the UK Biobank, a large, multi-source healthcare dataset.
Methods
Epilepsy, AD, FTD, and DLB cohorts were extracted. Cox proportional-hazard models were used to compare the AD risk in the epilepsy cohort against matched controls, and the epilepsy risk in the AD cohort against matched controls. Prevalent association of epilepsy with FTD and DLB was assessed using Chi-squared/Fisher test.
Results
Hazard-ratio (HR) for AD in the epilepsy population versus controls was 2.5 (1.8–3.4, p < 0.001); HR increased when epilepsy was diagnosed in the sixth-seventh decade and in individuals with epilepsy carrying the APOE ε4 allele. Conversely, HR for epilepsy in AD versus controls was 14.8 (9.7–22.5, p < 0.001). Epilepsy prevalence was higher in the FTD population compared to controls, with prevalence ratio (PR) of 5.3 (2.4–11.8, p = 0.001). Epilepsy PR in DLB versus controls approached but did not achieve statistical significance (2.4, 1.0–5.7, p = 0.068).
Conclusions
Our findings reinforce the notion of a bidirectional association between epilepsy and AD, providing proof-of-concept that epilepsy, especially late-onset, may be successfully integrated into AD risk frameworks. Furthermore, we found a high prevalence of epilepsy in the FTD population. Careful stratification of individuals with epilepsy could offer an opportunity to identify those at higher risk of future or covert AD and neurodegeneration.
GBD 2021 Nervous System Disorders Collaborators. Global, regional, and national burden of disorders affecting the nervous system, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol2024; 23: 344–381.
2.
GBD 2019 Dementia Forecasting Collaborators. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health2022; 7: e105–e125.
3.
SenAJetteNHusainM, et al.Epilepsy in older people. Lancet2020; 395: 735–748.
4.
HauserWAAnnegersJFKurlandLT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935–1984. Epilepsia1993; 34: 453–468.
5.
KnopmanDSAmievaHPetersenRC, et al.Alzheimer disease. Nat Rev Dis Primers2021; 7: 33.
6.
RamsayRERowanAJPryorFM. Special considerations in treating the elderly patient with epilepsy. Neurology2004; 62: S24–S29.
7.
ImfeldPBodmerMSchuerchM, et al.Seizures in patients with Alzheimer's disease or vascular dementia: a population-based nested case-control analysis. Epilepsia2013; 54: 700–707.
8.
ScarmeasNHonigLSChoiH, et al.Seizures in Alzheimer disease: who, when, and how common?Arch Neurol2009; 66: 992–997.
9.
IrizarryMCJinSHeF, et al.Incidence of new-onset seizures in mild to moderate Alzheimer disease. Arch Neurol2012; 69: 368–372.
10.
DiFrancescoJCTremolizzoLPoloniaV, et al.Adult-onset epilepsy in presymptomatic Alzheimer's disease: a retrospective study. J Alzheimers Dis2017; 60: 1267–1274.
11.
JohnsonELKraussGLKucharska-NewtonA, et al.Dementia in late-onset epilepsy: the Atherosclerosis Risk in Communities study. Neurology2020; 95: e3248–e3256.
12.
KeretOHoangTDXiaF, et al.Association of late-onset unprovoked seizures of unknown etiology with the risk of developing dementia in older veterans. JAMA Neurol2020; 77: 710–715.
13.
SchnierCDuncanSWilkinsonT, et al.A nationwide, retrospective, data-linkage, cohort study of epilepsy and incident dementia. Neurology2020; 95: e1686–e1693.
14.
TaiXYTorzilloELyallDM, et al.Association of dementia risk with focal epilepsy and modifiable cardiovascular risk factors. JAMA Neurol2023; 80: 445–454.
15.
ChuSFNiCHLiaoKH, et al.Dementia and epilepsy without traumatic brain injury among subjects middle-aged females: a population-based case-control study. J Alzheimers Dis2025; 103: 1171–1179.
16.
JohnsonELKraussGLLeeAK, et al.Association between midlife risk factors and late-onset epilepsy: results from the Atherosclerosis Risk in Communities Study. JAMA Neurol2018; 75: 1375–1382.
17.
PalopJJMuckeL. Network abnormalities and interneuron dysfunction in Alzheimer disease. Nat Rev Neurosci2016; 17: 777–792.
18.
RomoliMSenAParnettiL, et al.Amyloid-beta: a potential link between epilepsy and cognitive decline. Nat Rev Neurol2021; 17: 469–485.
19.
VosselKATartagliaMCNygaardHB, et al.Epileptic activity in Alzheimer's disease: causes and clinical relevance. Lancet Neurol2017; 16: 311–322.
20.
KamondiAGrigg-DambergerMLoscherW, et al.Epilepsy and epileptiform activity in late-onset Alzheimer disease: clinical and pathophysiological advances, gaps and conundrums. Nat Rev Neurol2024; 20: 162–182.
21.
TombiniMAssenzaGRicciL, et al.Temporal lobe epilepsy and Alzheimer's disease: from preclinical to clinical evidence of a strong association. J Alzheimers Dis Rep2021; 5: 243–261.
22.
VosselKARanasingheKGBeagleAJ, et al.Incidence and impact of subclinical epileptiform activity in Alzheimer's disease. Ann Neurol2016; 80: 858–870.
23.
LamADSarkisRAPellerinKR, et al.Association of epileptiform abnormalities and seizures in Alzheimer disease. Neurology2020; 95: e2259–e2270.
24.
HorvathAAPappAZsuffaJ, et al.Subclinical epileptiform activity accelerates the progression of Alzheimer's disease: a long-term EEG study. Clin Neurophysiol2021; 132: 1982–1989.
25.
CostaCParnettiLD'AmelioM, et al.Epilepsy, amyloid-beta, and D1 dopamine receptors: a possible pathogenetic link?Neurobiol Aging2016; 48: 161–171.
26.
CostaCRomoliMLiguoriC, et al.Alzheimer's disease and late-onset epilepsy of unknown origin: two faces of beta amyloid pathology. Neurobiol Aging2019; 73: 61–67.
27.
VosselKABeagleAJRabinoviciGD, et al.Seizures and epileptiform activity in the early stages of Alzheimer disease. JAMA Neurol2013; 70: 1158–1166.
28.
JohnsonELSullivanKJSchneiderALC, et al.Association of plasma Abeta(42)/Abeta(40) ratio and late-onset epilepsy: results from the Atherosclerosis Risk in Communities Study. Neurology2023; 101: e1319–e1327.
29.
CretinB. Epileptic variant in the spectrum of Alzheimer's disease - practical implications. Seizure2025; 128: 133–139.
30.
ZawarILuniewskiAGundlapalliR, et al.The association of seizure control with neuropathology in dementia. Brain2025; 148: 2469–2480.
31.
VosselKRanasingheKGBeagleAJ, et al.Effect of levetiracetam on cognition in patients with Alzheimer disease with and without epileptiform activity: a randomized clinical trial. JAMA Neurol2021; 78: 1345–1354.
32.
BeagleAJDarwishSMRanasingheKG, et al.Relative incidence of seizures and myoclonus in Alzheimer's disease, dementia with Lewy bodies, and frontotemporal dementia. J Alzheimers Dis2017; 60: 211–223.
33.
KilpelainenAAaltonenMAhoK, et al.Prevalence of epilepsy in frontotemporal dementia and timing of dementia diagnosis. JAMA Neurol2025; 82: 715–721.
SudlowCGallacherJAllenN, et al.UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med2015; 12: e1001779.
36.
BhattacharyyaJBarnesLLChenY, et al.Evaluating linked ICD-10 Medicare claims data as a method of dementia case ascertainment in research settings. Alzheimers Dement2025; 21: e70200.
37.
MbizvoGKBennettKHSchnierC, et al.The accuracy of using administrative healthcare data to identify epilepsy cases: a systematic review of validation studies. Epilepsia2020; 61: 1319–1335.
38.
Posit team (2025). RStudio: Integrated Development Environment for R. Posit Software, PBC, Boston, MA, http://www.posit.co/ (2026, accessed 3 April 2026).
39.
StamatakisEOwenKBShepherdL, et al.Is cohort representativeness passe? Poststratified associations of lifestyle risk factors with mortality in the UK Biobank. Epidemiology2021; 32: 179–188.
40.
SchoelerTSpeedDPorcuE, et al.Participation bias in the UK Biobank distorts genetic associations and downstream analyses. Nat Hum Behav2023; 7: 1216–1227.
41.
ZareaACharbonnierCRovelet-LecruxA, et al.Seizures in dominantly inherited Alzheimer disease. Neurology2016; 87: 912–919.
42.
BalleriniABiagioliNCarboneC, et al.Late-onset temporal lobe epilepsy: insights from brain atrophy and Alzheimer's disease biomarkers. Brain2025; 148: 185–198.
43.
GourmaudSShouHIrwinDJ, et al.Alzheimer-like amyloid and tau alterations associated with cognitive deficit in temporal lobe epilepsy. Brain2020; 143: 191–209.
44.
JoutsaJRinneJOHermannB, et al.Association between childhood-onset epilepsy and amyloid burden 5 decades later. JAMA Neurol2017; 74: 583–590.
45.
JoutsaJRinneJONiemiKJ, et al.Progression of amyloid accumulation in late adulthood among people with childhood-onset epilepsy. Neurology2025; 104: e210303.
46.
FangYSiXWangJ, et al.Alzheimer disease and epilepsy: a Mendelian randomization study. Neurology2023; 101: e399–e409.
47.
ZawarIQuiggMGhosalS, et al.Association of seizure control with mortality, cognition, and function in people with dementia. Ann Neurol2025; 97: 358–368.
48.
BrielsCTStamCJScheltensP, et al.The predictive value of normal EEGs in dementia due to Alzheimer's disease. Ann Clin Transl Neurol2021; 8: 1038–1048.
49.
LiuXde BoerSCMCortezK, et al.Sex differences in clinical phenotypes of behavioral variant frontotemporal dementia. Alzheimers Dement2025; 21: e14608.
Garcia-CabreroAMGuerrero-LopezRGiraldezBG, et al.Hyperexcitability and epileptic seizures in a model of frontotemporal dementia. Neurobiol Dis2013; 58: 200–208.
52.
SavicaRGrossardtBRBowerJH, et al.Incidence of dementia with Lewy bodies and Parkinson disease dementia. JAMA Neurol2013; 70: 1396–1402.
53.
DicksonDWHeckmanMGMurrayME, et al.APOE Epsilon4 is associated with severity of Lewy body pathology independent of Alzheimer pathology. Neurology2018; 91: e1182–e1195.
54.
MarawarRWakimNAlbinRL, et al.Seizure occurrence and related mortality in dementia with Lewy bodies. Epilepsy Behav2020; 111: 107311.
55.
HeppDHVergoossenDLHuismanE, et al.Distribution and load of amyloid-beta pathology in Parkinson disease and dementia with Lewy bodies. J Neuropathol Exp Neurol2016; 75: 936–945.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
